FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1193561004: Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4687650018 Azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/actuation nasal spray en Synonym Active Entire term case insensitive SNOMED CT core module
4687651019 Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has manufactured dose form Conventional release nasal spray true Inferred relationship Existential restriction modifier
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation Actuation true Inferred relationship Existential restriction modifier
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has precise active ingredient Azelastine hydrochloride true Inferred relationship Existential restriction modifier 1
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has basis of strength substance Azelastine hydrochloride true Inferred relationship Existential restriction modifier 1
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit Actuation true Inferred relationship Existential restriction modifier 1
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has precise active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier 2
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has basis of strength substance Fluticasone propionate true Inferred relationship Existential restriction modifier 2
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 2
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit Actuation true Inferred relationship Existential restriction modifier 2
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Is a Product containing only azelastine and fluticasone in nasal dose form (medicinal product form) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start